Hjem › Dermatomyositis › Ohio
Dermatomyositis kliniske forsøg i Ohio
5 studier for Dermatomyositis søger deltagere på steder i Ohio.
Byer i Ohio
Officiel studietekst (engelsk)
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
- Research Site, Cleveland
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 24. sep. 2026 · NCT06455449Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Ohio State University Comprehensive Cancer Center, Columbus
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT03816345A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
- Cleveland Clinic, Cleveland
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 15. sep. 2026 · NCT05895786Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders
- Cincinnati Children's Hospital Medical Center, Cincinnati
RekruttererFase 1/2
Alder 12 og opefter · Alle køn · Opdateret 27. jul. 2026 · NCT07089121Topical Ruxolitinib Cream for Refractory Cutaneous Dermatomyositis
- Cleveland Clinic, Cleveland
RekruttererFase 2
Alder 18 til 89 · Alle køn · Opdateret 8. okt. 2025 · NCT06857240Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.